Teleflex, Inc. (TFX) Tops Q2 EPS by 17c; Raises Outlook
Get Alerts TFX Hot Sheet
Revenue Growth %: -28.4%
Financial Fact:
Taxes on income from continuing operations: 7.51M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Teleflex, Inc. (NYSE: TFX) reported Q2 EPS of $1.51, $0.17 better than the analyst estimate of $1.34. Revenue for the quarter came in at $468.21 million versus the consensus estimate of $447.81 million.
Teleflex, Inc. sees FY2014 EPS of $5.45-$5.60, versus prior guidance of $5.35-$5.55 and the consensus of $5.51.
“Despite the impact of one less selling day in the second quarter of 2014 as compared to the prior year period, Teleflex delivered double-digit constant currency revenue and adjusted earnings per share growth,” said Benson Smith, Chairman, President and Chief Executive Officer. “Our second quarter performance was aided by the contribution from the acquisitions of Vidacare and Mayo Healthcare, an improvement in the average selling price of products, the introduction of new products to the market and a slight improvement in the sales of existing products resulting from a modest improvement in end-market utilization.”
Added Mr. Smith, “Based on the Company’s performance during the first six months of 2014, and our outlook for the remainder of the year, we are reaffirming our full year constant currency revenue growth guidance range of 7% to 9%, and increasing our full year adjusted diluted earnings per share guidance range from $5.35 to $5.55 to $5.45 to $5.60.”
For earnings history and earnings-related data on Teleflex, Inc. (TFX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- JPMorgan Upgrades SHIFT UP Corp (462870:KS) to Overweight
- SpaceX receives Baa1 rating from Moody's with stable outlook
Create E-mail Alert Related Categories
Earnings, Guidance, Management CommentsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share